Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
C
060590
vs
K
KOSPI 200
Over the past 12 months, CTC Bio Inc has underperformed KOSPI 200, delivering a return of -48% compared to KOSPI 200's +112% growth.
Stocks Performance
060590 vs KOSPI 200
Performance Gap
060590 vs KOSPI 200
Performance By Year
060590 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
CTC Bio Inc
Glance View
CTC Bio Inc makes and sells hospital and clinic products used in medical treatment, especially specialty medical devices and drug-related products. Its business is tied to everyday healthcare use rather than consumer sales, so it serves doctors, hospitals, distributors, and other medical buyers that need reliable supplies and finished products. The company earns money by selling these products directly and, in some cases, by supplying them through partners or contract arrangements. That means its revenue depends on how much its products are ordered for medical procedures, patient care, and related healthcare channels. What makes the business model different is that it sits in a narrow part of the healthcare supply chain: it is not a broad drug maker or a hospital operator, but a supplier of specialized products that need regulatory approval and consistent quality. That gives it a more technical, product-driven role in the market, with demand linked to medical usage and healthcare purchasing decisions.